Kaarsberg Clinical Services ApS: Financial statements 2025
CVR: 45692000
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Kaarsberg Clinical Services ApS (CVR 45692000) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,558,002 and a net result of DKK -439,891. Equity in the 2025 report amounted to DKK 1,448,901. The solvency ratio was 75.1%.
- Gross Profit
- DKK 1,558,002
- Profit/Loss
- DKK -439,891
- Equity
- DKK 1,448,901
- Total Assets
- DKK 1,929,605
Official annual report
How creditworthy is Kaarsberg Clinical Services ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of June 20, 2025, David Brinch Kaarsberg is registered as director of Kaarsberg Clinical Services ApS.
As of June 20, 2025, David Brinch Kaarsberg is registered as an owner of Kaarsberg Clinical Services ApS with an ownership share of 100%.
Kaarsberg Clinical Services ApS was founded on June 20, 2025.
About Kaarsberg Clinical Services ApS
Kaarsberg Clinical Services ApS is a Danish company of the type Anpartsselskab based in Næstved, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Brinch Kaarsberg. The company is owned by David Brinch Kaarsberg. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,558,002 and a net result of DKK -439,891. Equity in the 2025 report amounted to DKK 1,448,901.